Member Info for baz9707

Taff I do not think acacia are out completely hence no RNS.

1.5m buys in the 3p range then what looks like a placing 2m sell muged at 2.5p.
25% good for some.

I have put my own notes together on #nsci @NetScientific.
Pulls together $pdsb @ProAxsis
#Glycotest and the Seed PF.
If you want a PDF that gives the links let me know.
The value per share came out quite high but the mkt cap is pretty much covered by sellable assets. https://t.co/BEIHYDMf3c
https://twitter.com/Bazreynolds9707/status/1280575286778757120?s=19

Award
https://twitter.com/Bazreynolds9707/status/1279842540380991490?s=19

51% owned by Netscientific awarded funding for 12 week trial Covid tests in Ireland.
https://twitter.com/Bazreynolds9707/status/1279842540380991490?s=19

https://twitter.com/ProAxsis/status/1277628396990857216?s=19

Let's get it out the way invest and move the SP up.

The real re rate will be when either Glycotest or ProAxsis are sold or valued properly.
PDSB shares now worth 4m and the 1m plus value of the Seed fund is an added bonus which covers the mkt cap.
44p is a cheap valuation.

I hear that news ref Covid vaccine could be tomorrow hence the buying.
15m shares in issue 10m in public blish float and 1m held by Netscientific, going to be 30m traded just today amazing volume.

Follow he link message from netscientific CFO Stephen Crowe from Friday.
I will do my own note on the company just to see how close I am when the new valuation comes out.
https://twitter.com/Bazreynolds9707/status/1276459497758703616?s=19

Definately undervalued and the SP will go on a run soon, only good news coming from the company.

Take a look at the SP on the NASDAQ

With more news due the next 2 weeks could see the start of a re- rate.
Company will be looking to up the PR now the Woodford debacle is nearly over.

G-Tech valued at 400k after £6.7m series A, previously valued £0.
Seed PF now worth £1m alone on the book.
https://twitter.com/Bazreynolds9707/status/1277484798521544706?s=19

Please look at the the register again 79m shares in issue
46.5m long term major Shareholders
8.1m Acacia who have or maybe not sold

Message from Stephen Crowe CFO
https://twitter.com/Bazreynolds9707/status/1276459497758703616?s=19

Edison note with some updated figures based on % probability of success.
https://twitter.com/Bazreynolds9707/status/1276254244576866304?s=19

https://twitter.com/Bazreynolds9707/status/1276208859791663108?s=19
Fully funded into 2021
#NSCI No placing, 3.5m cash enough to see them well into 2021
300k Epibone shares
400k CytoVale shares
700k Drawdown facility
Glycotest 20m value
ProAxsis commercial
All funded
$pdsb ??
M Lawson 30% pushing for shareholder value through sale of assets at the right price and Divi https://t.co/neJqJ5pZcf

https://twitter.com/Bazreynolds9707/status/1276143239385448454?s=19

JBER came on to the scene on the 18th, in my opinion they took the 7.5m shares at 6p with no liquidity.
They have now pretty much sold them on, acacia might see this liquidity and look to offload the rest or manage them in new office they are setting up in Oxford, really no one knows until there is another RNS.
Massively undervalued at this price.